Büşra Çelikkaya

Büşra Çelikkaya

Auto-generated profile, based on publicly available information

Büşra Çelikkaya

Department of Cancer Molecular Biology, Institute of Health Sciences, Pamukkale University, Denizli, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
OTOnur Tonk
Onur Tonk
PTPervin Elvan Tokgun
Pervin Elvan Tokgun
ÖYÖzge Sarıca Yılmaz
Özge Sarıca Yılmaz
OTOnur Tokgun
Onur Tokgun
KIKubilay Inci
Kubilay Inci
NANuray Altintas
Nuray Altintas
This study aimed to analyze the possible association of miR-30a-5p, miR-30e-5p, and miR-34a-5p identified as potential candidate miRNAs in schizophrenia, with the COMT gene. Candidate miRNAs were obtained from the TargetScan database. The SH-SY5Y human neuroblastoma cell line was used as a cellular model for schizophrenia. miR-30a-5p, miR-30e-5p, and miR-34a-5p mimics were transfected into the SH-SY5Y cell line. Total RNA was isolated from transfected cells and RNA-IP samples and reverse transcripted for miRNA and mRNA analysis. RT-qPCR and western blot were performed to observe changes in expression levels of COMT. RNA-ımmunoprecipitation was performed to determine RNA–protein interactions after mimic transfection. In the study, it was observed that COMT gene expression levels decreased significantly after miR-30a-5p and miR-34a-5p expressions, whereas increased significantly as a result of miR-30e-5p transfection. RNA-IP data have shown that the amount of COMT pulled down by Ago2 was increased after miR-30a-5p and miR-34a-5p transfections. RNA-IP results revealed that miR-30a-5p and miR-34a-5p are direct targets for the COMT gene.

29 April 2023 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
BCBusra Celikkaya
Busra Celikkaya
TDTaner Durak
Taner Durak
AFAmmad Farooqi
Ammad Farooqi
KIKubilay Inci
Kubilay Inci
PTPervin Elvan Tokgun
Pervin Elvan Tokgun
OTOnur Tokgun
Onur Tokgun

19 March 2024 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
OTOnur Tonk
Onur Tonk
PTPervin Elvan Tokgun
Pervin Elvan Tokgun
ÖYÖzge Sarıca Yılmaz
Özge Sarıca Yılmaz
OTOnur Tokgun
Onur Tokgun
KIKubilay Inci
Kubilay Inci
NANuray Altintas
Nuray Altintas

31 October 2023 in Doğu Karadeniz Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
KIKubilay Incı
Kubilay Incı
BÇBüşra Çeli̇kkaya
Büşra Çeli̇kkaya
NINesrin İrEp
Nesrin İrEp
AGAziz Gültekin
Aziz Gültekin
OTOnur Tokgün
Onur Tokgün
Small cell lung cancer (SCLC) is characterized by rapid growth and early metastasis. Identifying new molecular targets are important in the pathogenesis of SCLC in order to develop new treatment strategies. RAB27A is the critical protein for intracellular exosome trafficking and is a driver of tumour progression. However, demonstrating the potential impact of suppressing RAB27A in SCLC as therapeutic approach is an important deficiency. RAB27A gene knockout SCLC cell lines were generated using a CRISPR/cas9 system. qRT-PCR, Western blotting and Sanger sequencing were performed to confirm RAB27A knockout in SCLC cells. TEM and EXOCET assays were used to detect the alteration of exosomes. Proliferation and colony formation were detected by MTT and microscopy. Subsequently, we intrapulmonally injected N417 and H524 SCLC cells(control and RAB27A knockout for each cell) into SCID mice. The effects of RAB27A knockout on mouse tumor model were analysed using 18F-FDG PET/CT scans.Knocking out RAB27A significantly decreased the expression of CD9, CD63, Tsg101, exosome secretion and exosomal protein in SCLC(p